CL Stock Overview
Manufactures and sells consumer products in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Colgate-Palmolive Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$92.03 |
| 52 Week High | US$109.30 |
| 52 Week Low | US$77.98 |
| Beta | 0.42 |
| 1 Month Change | -2.00% |
| 3 Month Change | -10.70% |
| 1 Year Change | 17.24% |
| 3 Year Change | 11.16% |
| 5 Year Change | 33.03% |
| Change since IPO | 9,854.80% |
Recent News & Updates
Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Dec 18
Colgate-Palmolive: Digital Advertising Is The Base From Which To Start Again
Dec 17Colgate-Palmolive: Approaching Buy Territory With Some Important Catalysts
Dec 11Recent updates
Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Dec 18Colgate-Palmolive: Digital Advertising Is The Base From Which To Start Again
Dec 17Colgate-Palmolive: Approaching Buy Territory With Some Important Catalysts
Dec 11Colgate-Palmolive Company's (NYSE:CL) Share Price Not Quite Adding Up
Dec 03Colgate-Palmolive Company's (NYSE:CL) Intrinsic Value Is Potentially 63% Above Its Share Price
Nov 20If EPS Growth Is Important To You, Colgate-Palmolive (NYSE:CL) Presents An Opportunity
Oct 26Colgate-Palmolive Q3: Great Company, But Not Enough To Warrant A Position Now
Oct 25Colgate-Palmolive: Very Close To A Buy Following Recent Pullback
Oct 17Colgate-Palmolive: Share Price Returns Should Moderate (Rating Downgrade)
Sep 30These 4 Measures Indicate That Colgate-Palmolive (NYSE:CL) Is Using Debt Reasonably Well
Sep 11Returns At Colgate-Palmolive (NYSE:CL) Appear To Be Weighed Down
Aug 27Colgate-Palmolive: Stability Pillar Reached Its Fair Value
Aug 19An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued
Aug 12Colgate-Palmolive: Good Growth Prospects Ahead
Aug 06Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)
Jul 11Colgate-Palmolive: Three Items To Look For In The Upcoming Earnings
Jul 10Colgate-Palmolive: Gladly Holding, Yet Currently Not Buying An All Time Favorite
Jun 23Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Jun 06Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital
May 21Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report
Apr 30Colgate-Palmolive: Loading Up Ahead Of Earnings
Apr 16Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E
Apr 02Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 18Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?
Feb 14Colgate-Palmolive: I'm Buying Before Interest Rates Decrease
Feb 14Colgate-Palmolive: Brushing Up Profits In Q4 2023
Jan 30Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Jan 19Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult
Jan 01Colgate-Palmolive: A Better Year Ahead (Rating Upgrade)
Dec 20Colgate-Palmolive Stock And Its Real Value
Nov 29Brush Up With Colgate-Palmolive Stock As Earnings Growth Drips On
Nov 14Colgate-Palmolive: Own This Dividend King At The Right Price
Oct 31Why Colgate-Palmolive Is A Bargain You Shouldn't Ignore Right Now
Oct 13Colgate-Palmolive: Dividend King With Limited Growth
Sep 27Colgate-Palmolive: Improving Prospects And A Reasonable Valuation
Sep 09Colgate-Palmolive: A Healthy 7% Return With A Safe Dividend For Investors In A Post-Pandemic World
Aug 16Colgate And The Importance Of Sales Growth, Expectations Matter
Aug 09Colgate-Palmolive: Challenging Growth Prospects
Jul 10Shareholder Returns
| CL | US Household Products | US Market | |
|---|---|---|---|
| 7D | -1.5% | -1.5% | -2.4% |
| 1Y | 17.2% | 14.5% | 23.3% |
Return vs Industry: CL exceeded the US Household Products industry which returned 14.5% over the past year.
Return vs Market: CL underperformed the US Market which returned 23.3% over the past year.
Price Volatility
| CL volatility | |
|---|---|
| CL Average Weekly Movement | 2.6% |
| Household Products Industry Average Movement | 3.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CL has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: CL's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1806 | 34,000 | Noel Wallace | www.colgatepalmolive.com |
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Colgate-Palmolive Company Fundamentals Summary
| CL fundamental statistics | |
|---|---|
| Market cap | US$75.92b |
| Earnings (TTM) | US$2.87b |
| Revenue (TTM) | US$20.11b |
26.2x
P/E Ratio3.7x
P/S RatioIs CL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CL income statement (TTM) | |
|---|---|
| Revenue | US$20.11b |
| Cost of Revenue | US$7.96b |
| Gross Profit | US$12.15b |
| Other Expenses | US$9.28b |
| Earnings | US$2.87b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.51 |
| Gross Margin | 60.42% |
| Net Profit Margin | 14.26% |
| Debt/Equity Ratio | 1,009.1% |
How did CL perform over the long term?
See historical performance and comparisonDividends
2.2%
Current Dividend Yield56%
Payout RatioDoes CL pay a reliable dividends?
See CL dividend history and benchmarks| Colgate-Palmolive dividend dates | |
|---|---|
| Ex Dividend Date | Jan 21 2025 |
| Dividend Pay Date | Feb 14 2025 |
| Days until Ex dividend | 31 days |
| Days until Dividend pay date | 55 days |
Does CL pay a reliable dividends?
See CL dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 05:17 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Colgate-Palmolive Company is covered by 54 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christopher Graja | Argus Research Company |
| Edward Lewis | Atlantic Equities LLP |
| Ishan Majumdar | Baptista Research |